rs782465732
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM1PM2PP3_Moderate
The NM_000260.4(MYO7A):c.3451C>G(p.Leu1151Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000118 in 1,442,406 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000260.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO7A | ENST00000409709.9 | c.3451C>G | p.Leu1151Val | missense_variant | Exon 27 of 49 | 1 | NM_000260.4 | ENSP00000386331.3 | ||
MYO7A | ENST00000458637.6 | c.3451C>G | p.Leu1151Val | missense_variant | Exon 27 of 49 | 1 | ENSP00000392185.2 | |||
MYO7A | ENST00000409619.6 | c.3418C>G | p.Leu1140Val | missense_variant | Exon 28 of 50 | 1 | ENSP00000386635.2 | |||
MYO7A | ENST00000458169.2 | c.994C>G | p.Leu332Val | missense_variant | Exon 7 of 29 | 1 | ENSP00000417017.2 | |||
MYO7A | ENST00000670577.1 | n.1291C>G | non_coding_transcript_exon_variant | Exon 10 of 32 | ENSP00000499323.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000183 AC: 4AN: 218150Hom.: 0 AF XY: 0.0000170 AC XY: 2AN XY: 117952
GnomAD4 exome AF: 0.0000118 AC: 17AN: 1442406Hom.: 0 Cov.: 31 AF XY: 0.0000168 AC XY: 12AN XY: 715568
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Benign. The p.Leu1151Val va riant in MYO7A has been reported in trans with a likely pathogenic variant in on e individual with hearing loss and one unaffected sibling. This variant has been identified in 1/24050 European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org). Although this variant has been seen in t he general population, its frequency is not high enough to rule out a pathogenic role. Computational prediction tools and conservation analyses suggest that the p.Leu1151Val variant may impact the protein, though this information is not pre dictive enough to determine pathogenicity. While the clinical significance of th e p.Leu1151Val variant is uncertain, it is likely to be benign because it is lik ely in trans with a likely pathogenic variant in MYO7 in a reportedly unaffected individual. -
Usher syndrome type 1;C1838701:Autosomal recessive nonsyndromic hearing loss 2 Uncertain:1
- -
not provided Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MYO7A protein function. ClinVar contains an entry for this variant (Variation ID: 229011). This variant has not been reported in the literature in individuals affected with MYO7A-related conditions. This variant is present in population databases (rs782465732, gnomAD 0.002%). This sequence change replaces leucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 1151 of the MYO7A protein (p.Leu1151Val). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at